GIP
NAGE

Granite Investment Partners’s Niagen Bioscience NAGE Stock Holding History

Granite Investment Partners’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,743
Closed -$51K – 314
2019
Q4 		$51K Sell
11,743
-77,573
-87% -$276K ﹤0.01% 282
2019
Q3 		$351K Hold
89,316
– – 0.02% 292
2019
Q2 		$415K Sell
89,316
-78,373
-47% -$334K 0.02% 286
2019
Q1 		$702K Buy
167,689
+78,373
+88% +$283K 0.04% 276
2018
Q4 		$307K Hold
89,316
– – 0.02% 295
2018
Q3 		$383K Hold
89,316
– – 0.02% 265
2018
Q2 		$332K Hold
89,316
– – 0.02% 270
2018
Q1 		$375K Sell
89,316
-160,960
-64% -$843K 0.03% 243
2017
Q4 		$1.47M Hold
250,276
– – 0.09% 170
2017
Q3 		$1.08M Buy
250,276
+13,599
+6% +$49.7K 0.07% 204
2017
Q2 		$904K Sell
236,677
-11,537
-5% -$36.5K 0.06% 243
2017
Q1 		$667K Sell
248,214
-6,024
-2% -$17.1K 0.05% 266
2016
Q4 		$842K Sell
254,238
-26,812
-10% -$72.9K 0.06% 247
2016
Q3 		$837K Buy
281,050
+144,987
+107% +$532K 0.06% 255
2016
Q2 		$564K Buy
+136,063
New +$644K 0.04% 267

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SA
Sycale Advisors New York $201M AUM 2.35% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

Granite Investment Partners's NAGE Position: Q1 2020 in Review

Granite Investment Partners sold out of Niagen Bioscience (NAGE) in Q1 2020, closing a stake of 11,743 shares — an estimated $51K sold.

Granite Investment Partners first reported a position in NAGE in Q2 2016 and held it in 15 quarters. The position peaked at $1.47M in Q4 2017. 61 funds tracked by Wall St. Rank hold NAGE as of Q1 2020.

  • Granite Investment Partners reported no remaining Niagen Bioscience position as of Q1 2020 after selling out during the quarter.
  • Granite Investment Partners sold 11,743 Niagen Bioscience shares in Q1 2020, an estimated $51K.
  • Granite Investment Partners first reported a position in Niagen Bioscience in Q2 2016 and held it in 15 quarters.
  • Granite Investment Partners's Niagen Bioscience position peaked at $1.47M in Q4 2017.
  • 61 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2020.

Based on Granite Investment Partners's 13F filing for Q1 2020, filed 14 May 2020.